statistiche ricercatore

statistiche per CATTINA, FEDERICA

Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1182
EU - Europa 1085
AS - Asia 514
AF - Africa 46
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 2834
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1179
GB - Regno Unito 532
CN - Cina 289
SE - Svezia 173
IT - Italia 109
VN - Vietnam 108
IN - India 99
RU - Federazione Russa 68
FR - Francia 65
ZA - Sudafrica 45
EE - Estonia 41
DE - Germania 40
UA - Ucraina 28
GR - Grecia 16
CH - Svizzera 5
LB - Libano 5
TR - Turchia 5
KR - Corea 3
NL - Olanda 3
AT - Austria 2
AU - Australia 2
CA - Canada 2
CZ - Repubblica Ceca 2
HK - Hong Kong 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BR - Brasile 1
CL - Cile 1
EU - Europa 1
ID - Indonesia 1
MX - Messico 1
PL - Polonia 1
SC - Seychelles 1
Totale 2834
Salva come PNG Salva come JPEG
Città #
Southend 504
Fairfield 225
Houston 132
Ann Arbor 127
Seattle 117
Ashburn 116
Woodbridge 112
Wilmington 103
Dong Ket 76
Cambridge 73
Nanjing 51
Beijing 50
Westminster 50
Padova 49
Bologna 30
Hebei 25
Jinan 23
Saint Petersburg 23
Shenyang 21
Nanchang 20
Changsha 18
San Diego 15
Tianjin 10
Jiaxing 9
Ningbo 8
Redwood City 8
Hangzhou 7
Dearborn 6
Guangzhou 5
Haikou 5
Kunming 5
Lanzhou 5
Taiyuan 5
Taizhou 5
Falls Church 4
Fuzhou 4
Grafing 4
Las Vegas 4
Zhengzhou 4
Bursa 3
Lausanne 3
Athens 2
Baltimore 2
Central District 2
Costa Mesa 2
Den Haag 2
Frankfurt Am Main 2
Istanbul 2
Kuban 2
Milan 2
Monmouth Junction 2
North York 2
Norwalk 2
Orange 2
Phoenix 2
Plauen 2
Riva 2
Rome 2
Brisbane 1
Broni 1
Buenos Aires 1
Buffalo 1
Carol Stream 1
Changchun 1
Chongqing 1
Como 1
Duncan 1
Fontenay-aux-roses 1
Fremont 1
Fusignano 1
Guiyang 1
Hefei 1
Jacksonville 1
Jakarta 1
Jesolo 1
Kiev 1
Leawood 1
London 1
Madero 1
Mahé 1
Napoli 1
North Vernon 1
Nürnberg 1
Philadelphia 1
Portici 1
Provo 1
Quzhou 1
Richmond 1
Riolo Terme 1
Roubaix 1
Rovereto 1
San Jose 1
San Mateo 1
Santiago 1
Tucson 1
Ulan-ude 1
Totale 2136
Salva come PNG Salva come JPEG
Nome #
CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. 124
ARF Loss, a Negative Prognostic Factor in Philadelphia-Positive Acute Lymphoblastic Leukemia, May Be Efficiently Overcome by the Small Molecule MDM2 Antagonist RG7112 105
Assessment of BCR-ABL1 Transcript Levels By Digital PCR (dPCR) in CML Patients who Achieved a Deep Molecular Response (DMR: MR4.0, MR4.5 And MR5.0) with Tkis May Improve the Detection of Minimal Residual Disease (MRD) and the Selection of Patients for Treatment Free Remission (TFR) 101
Use of a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript In Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL). 89
RALE051: a novel established cell line of sporadic Burkitt lymphoma 87
Targeting the p53-MDM2 interaction by the small-molecule MDM2 antagonist Nutlin-3a: A new challenged target therapy in adult Philadelphia positive acute lymphoblastic leukemia patients 84
SIRPB1 Is a Strong Predictor Biomarker of Response to 5-Azacitidine Therapy in MDS and AML Patients 84
Profiling of drug-metabolizing enzymes/transporters in CD33+ acute myeloid leukemia patients treated with Gemtuzumab-Ozogamicin and Fludarabine, Cytarabine and Idarubicin 76
In Vitro and in Vivo Single-Agent Efficacy of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) Inhibitor PF-0477736 (Pfizer) in B- and T-Acute Lymphoblastic Leukemia (ALL) 75
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response 75
The Small Molecule CHK1/CHK2 Inhibitor PF-0477736 (Pfizer) Demonstrates Single Agent Activity and Synergizes with Chemotherapy in Diffuse Large B-Cell Lymphoma 73
Gas1 and Kif27 genes are strongly up-regulated biomarkers of Hedgehog inhibition (PF-04449913) on leukemia stem cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia treated patients 72
The Novel Small Molecule Chk1/Chk2 Inhibitor PF-0477736 (Pfizer) Is Highly Active As Single Agent in Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ ALL) 72
The role of the loss of CDKN2A gene on prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia (ALL) 68
TP53 Alterations Including Missense Mutations, Aberrant Exon-Junctions and Internal Intron Retentions Are Frequent and May Contribute to MDM2 Antagonist-Resistance in B-Acute Lymphoblastic leukemia 68
Revealing very small FLT3 ITD mutated clones by ultra-deep sequencing analysis has important clinical implications in AML patients 67
A germline polymorphism in the ANRIL (CDKN2BAS) locus is associated with susceptibility to Philadelphia-positive acute lymphoblastic leukemia (ALL) 66
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 66
Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain Allows Earlier Detection and More Accurate Characterization of Resistant Subclones in Philadelphia-Positive Acute Lymphoblastic Leukemia Patients Receiving Tyrosine Kinase Inhibitor-Based Therapies 65
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications 65
Inhibition of Checkpoint Kinase 1 (Chk1) and 2 (Chk2) is a novel therapeutic strategy in B- and T-Acute Lymphoblastic Leukemia (ALL). 61
Loss of Heterozygosity At the C Wild-Type Allele of rs1042522 in the TP53 Gene Frequently Occurs During Progression of Adult BCR-ABL1 Positive Acute Lymphoblastic Leukemia (ALL) 59
null 59
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 59
Mesenchymal stromal cells (MSCs) induce ex vivo proliferation and erythroid commitment of cord blood haematopoietic stem cells (CB-CD34+ cells) 58
Down-Regulation of BMI-1 Is a New Marker of Sensitivity to Mdm2 Inhibition in B-Acute Lymphoblastic Leukemia. 57
PF-04449913 Reverts Multi Drug Resistance (MDR) by a Strong Down-Regulation of ABCA2 and BCL2 on Leukemia Stem Cells in Phase I Acute Myeloid Leukemia and Chronic Myeloid Leukemia Treated Patients 57
PF-04449913 reverts multi drug resistance (MDR) by a strong down-regulation of ABCA2 and BCL2 on leukemia stem cells in phase I acute myeloid leukemia and chronic myeloid leukemia treated patients 56
null 55
Ultra-Deep Sequencing Strategy Is a Precious Tool to Find Small Clones Harbouring FLT3 Mutations in AML Patients 55
Resistance to second-line tyrosine kinase inhibitor treatment in imatinib-resistant Philadelphia-positive leukemia patients can be anticipated by ultra-deep sequencing of the BCR-ABL kinase domain using Roche 454 technology 54
Dissecting the Complexity of Philadelphia-Positive Mutated Populations by Ultra-Deep Sequencing of the Bcr-Abl Kinase Domain: Biological and Clinical Implications 53
null 52
Inhibition of DNA repair by the small molecule Chk1/Chk2 inhibitor PF-0477736 (Pfizer) in B-acute lymphoblastic leukemia (ALL) 51
null 50
Digital PCR (dPCR) Overcomes the Limitations in Detection and in Quantification of Quantitative PCR (qPCR) and Reveals Different Levels of BCR-ABL1 Copies/µl Among the Chronic Myeloid Leukemia (CML) Patients Achieving Major (MR3.0) or DEEP (MR4.0, MR4.5 and MR5.0) Molecular Response with Tyrosin Kynase Inhibitors (TKIs) 50
Tp53 mutation screening in adult acute myeloid leukemia (AML) patients shows a strong association with complex karyotype and poor outcome 50
The small molecule CHK1/CHK2 inhibitor PF-0477736 (Pfizer) demonstrates single agent activity in diffuse large B-cell lymphoma 49
TP53 mutations are mutually exclusive with FLT3 and NPM mutations in AML patients and are strongly associated with complex karyotype and poor outcome 49
null 44
null 42
null 40
null 38
null 38
null 38
null 37
PROSPECTIVE PHASE II STUDY ON LOW-DOSE 5-AZACYTIDINE FOR TREATMENT OF SYMPTOMATIC PATIENTS WITH LOW/INT-1 RISK MYELODISPLASIA 31
Loss of the tumor suppressor genes CDKN2A/ARF impairs prognosis in adult BCR-ABL1 positive acute lymphoblastic leukemia (ALL) 29
Totale 2953
Salva come PNG Salva come JPEG
Categoria #
all - tutte 2953
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2953
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2016/20171 0000 00 00 0010
2017/2018148 4000 86 18 701095
2018/2019356 553321 853 2011 26492681
2019/20201211 19647494 109108 135112 173846881
2020/2021595 12531109 2821 1739 543543183
2021/2022629 64136467 10669 1348 4678610
Totale 2953
 
 
 
Powered by IRIS-about IRIS-Utilizzo dei cookie
Logo CINECA  Copyright © 2022